🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › Illinois › Chicago

Etid klinik pou Kansè renn (Kasinom selil renn) nan Chicago, IL

8 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • ak 1 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #26, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Rush MD Anderson Cancer Center, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Ap rekriteFaz 2
  • Northwestern University, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05327686

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Ap rekriteFaz 3
  • Northwestern University, Chicago
  • Rush MD Anderson Cancer Center, Chicago
  • University of Illinois, Chicago
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06661720

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 1
  • Xencor Investigative Site, Chicago
  • Xencor Investigative Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT05433142

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Ap rekriteFaz 3
  • Northwestern University, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois, Chicago
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597

Etid Kansè renn (Kasinom selil renn) nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.